Clairton, PA, United States of America

James L Mather



Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Pittsburgh, PA (US) (2017)
  • Clairton, PA (US) (2018 - 2019)

Company Filing History:


Years Active: 2017-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: **James L. Mather: Innovator in ALS Treatment**

Introduction

James L. Mather is an accomplished inventor based in Clairton, Pennsylvania, recognized for his significant contributions to the field of medical research. With three patents to his name, Mather is particularly noted for his pioneering work focused on treatments for amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease.

Latest Patents

Mather's recent patents include breakthrough methodologies for treating ALS in responders. These patents detail a method that involves administering an effective amount of (6R)-2-amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole or its pharmaceutically acceptable salts to subjects who are identified as treatment responders. Specifically, the patents highlight certain characteristics of suitable subjects, including those with definite ALS, a symptom onset duration of less than about 18 months, elevated serum creatinine levels, and those undergoing concomitant riluzole administration.

Career Highlights

James L. Mather works at Knopp Biosciences, LLC, an organization that specializes in drug discovery and development for neurodegenerative disorders. His dedication to advancing ALS treatments showcases his commitment to enhancing patient care and improving outcomes for individuals afflicted with this challenging disease.

Collaborations

Throughout his career, Mather has collaborated with notable peers, such as Michael E. Bozik and Thomas Petzinger, Jr. These partnerships underscore the collective effort within the scientific community to tackle complex medical issues and bring innovative solutions to patients.

Conclusion

In conclusion, James L. Mather stands out as a key figure in the innovative treatment of ALS. His patents and work at Knopp Biosciences reflect a dedication to advancing medical research and improving the quality of life for those affected by this debilitating condition. With ongoing collaborations and a profound commitment to innovation, Mather continues to be a vital contributor in his field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…